Rapid Medical Diagnostic Kits Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Rapid Medical Diagnostic Kits Market, By Product

7.1.  Rapid Medical Diagnostic Kits Market, by Product Type, 2020-2030

7.1.1.    Over the Counter (OTC) Kits

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Professional Kits

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Rapid Medical Diagnostic Kits Market, By Autonomy

8.1.  Rapid Medical Diagnostic Kits Market, by Autonomy, 2020-2030

8.1.1.    Lateral Flow

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Agglutination

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Solid Phase

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Other Technologies

8.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Rapid Medical Diagnostic Kits Market, By Propulsion Type

9.1.  Rapid Medical Diagnostic Kits Market, by Propulsion Type, 2020-2030

9.1.1.    Blood Glucose Testing

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Infectious Disease Testing

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Cardiometabolic Testing

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Pregnancy and Fertility Testing

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Fecal Occult Blood Testing

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    Coagulation Testing

9.1.6.1.        Market Revenue and Forecast (2016-2030)

9.1.7.    Toxicology Testing

9.1.7.1.        Market Revenue and Forecast (2016-2030)

9.1.8.    Lipid Profile Testing

9.1.8.1.        Market Revenue and Forecast (2016-2030)

9.1.9.    Other Applications

9.1.9.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Rapid Medical Diagnostic Kits Market, By End-use Type

10.1.        Rapid Medical Diagnostic Kits Market, By End-use Type, 2020-2030

10.1.1.  Hospitals & Clinics

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Home Care

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Diagnostic Laboratories

10.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Rapid Medical Diagnostic Kits Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2016-2030)

11.1.2.  Market Revenue and Forecast, by Autonomy (2016-2030)

11.1.3.  Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.1.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.5.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.1.5.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.1.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.6.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.1.6.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.1.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2016-2030)

11.2.2.  Market Revenue and Forecast, by Autonomy (2016-2030)

11.2.3.  Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.2.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.5.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.2.5.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.2.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.6.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.2.6.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.2.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.7.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.2.7.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.2.7.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.8.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.2.8.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.2.8.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2016-2030)

11.3.2.  Market Revenue and Forecast, by Autonomy (2016-2030)

11.3.3.  Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.3.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.5.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.3.5.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.3.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.6.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.3.6.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.3.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.7.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.3.7.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.3.7.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.8.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.3.8.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.3.8.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2016-2030)

11.4.2.  Market Revenue and Forecast, by Autonomy (2016-2030)

11.4.3.  Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.4.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.5.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.4.5.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.4.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.6.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.4.6.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.4.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.7.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.4.7.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.4.7.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.8.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.4.8.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.4.8.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2016-2030)

11.5.2.  Market Revenue and Forecast, by Autonomy (2016-2030)

11.5.3.  Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.5.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.5.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.5.5.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.5.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.6.2.      Market Revenue and Forecast, by Autonomy (2016-2030)

11.5.6.3.      Market Revenue and Forecast, by Propulsion Type (2016-2030)

11.5.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

Chapter 12.  Company Profiles

12.1.              ACON Laboratories, Inc.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Abbott Laboratories

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Artron Laboratories Inc.

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Alfa Scientific Designs, Inc.

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Becton, Dickinson and Company

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              BTNX, Inc.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              bioMérieux SA

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Cardinal Health

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Bio-Rad Laboratories, Inc.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Danaher Corporation

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Creative Diagnostics

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           Meridian Bioscience, Inc.

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           F. Hoffmann-La Roche AG

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

12.14.           McKesson Medical-Surgical, Inc.

12.14.1.               Company Overview

12.14.2.               Product Offerings

12.14.3.               Financial Performance

12.14.4.               Recent Initiatives

12.15.           Sight Diagnostics Ltd.

12.15.1.               Company Overview

12.15.2.               Product Offerings

12.15.3.               Financial Performance

12.15.4.               Recent Initiatives

12.16.           Trinity Biotech

12.16.1.               Company Overview

12.16.2.               Product Offerings

12.16.3.               Financial Performance

12.16.4.               Recent Initiatives

12.17.           Zoetis

12.17.1.               Company Overview

12.17.2.               Product Offerings

12.17.3.               Financial Performance

12.17.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms